Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers

[1]  M. Kanda,et al.  A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer , 2022, Gastric Cancer.

[2]  Joon-Oh Park,et al.  An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: A multicenter cohort study. , 2022, Gastroenterology.

[3]  Jasjit K. Banwait,et al.  A Liquid Biopsy Signature for the Detection of Patients with Early-Onset Colorectal Cancer. , 2022, Gastroenterology.

[4]  J. Lindberg,et al.  ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  M. Kanda,et al.  Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer , 2022, International journal of oncology.

[6]  M. Kanda,et al.  Prognostic Value of a Modified Albumin–Bilirubin Score Designed for Patients with Esophageal Squamous Cell Carcinoma After Radical Resection , 2022, Annals of Surgical Oncology.

[7]  M. Kanda,et al.  Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells , 2022, Gastric Cancer.

[8]  M. Kanda,et al.  A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study , 2022, Molecular cancer.

[9]  M. Kanda,et al.  Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer , 2022, Molecular cancer.

[10]  M. Kanda,et al.  Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer , 2021, JAMA network open.

[11]  M. Kanda,et al.  Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells , 2021, Oncogene.

[12]  Shi Feng,et al.  SDF4 Is a Prognostic Factor for 28-Days Mortality in Patients With Sepsis via Negatively Regulating ER Stress , 2021, Frontiers in Immunology.

[13]  X. Wan,et al.  Fibroblast CEBPD/SDF4 axis in response to chemotherapy-induced angiogenesis through CXCR4 , 2021, Cell death discovery.

[14]  M. Kanda,et al.  Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer , 2020, Molecular therapy. Nucleic acids.

[15]  M. Kanda,et al.  Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer , 2020, Molecular Cancer.

[16]  M. Kanda,et al.  D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset , 2020, Surgery Today.

[17]  Wei Liu,et al.  A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic , 2019, Cancer science.

[18]  M. Kanda,et al.  Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study , 2019, Gastric Cancer.

[19]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[20]  S. Liu,et al.  Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  K. Kumamoto,et al.  Clinical significance of serum anti-p53 antibody expression following curative surgery for colorectal cancer. , 2017, Molecular and clinical oncology.

[22]  M. Kanda,et al.  Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[23]  Hong Zhu,et al.  A Novel Role of Cab45-G in Mediating Cell Migration in Cancer Cells , 2016, International journal of biological sciences.

[24]  M. Kanda,et al.  Function and diagnostic value of Anosmin‐1 in gastric cancer progression , 2016, International journal of cancer.

[25]  M. Kanda,et al.  The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression , 2016, Annals of Surgical Oncology.

[26]  Y. Xu,et al.  Cab45S promotes cell proliferation through SERCA2b inhibition and Ca2+ signaling , 2016, Oncogene.

[27]  M. Kanda,et al.  Recent advances in the molecular diagnostics of gastric cancer. , 2015, World journal of gastroenterology.

[28]  Amir Feizi,et al.  HCSD: the human cancer secretome database , 2015, Database J. Biol. Databases Curation.

[29]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[30]  M. Kanda,et al.  Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer , 2014, Journal of experimental & clinical cancer research : CR.

[31]  S. Fisher,et al.  Stromal cell derived factor-2 (Sdf2): a novel protein expressed in mouse. , 2014, The international journal of biochemistry & cell biology.

[32]  Kun-He Zhang,et al.  Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer , 2013, BMC Gastroenterology.

[33]  Anne-Marie Alleaume,et al.  Cab45 is required for Ca2+-dependent secretory cargo sorting at the trans-Golgi network , 2012, The Journal of cell biology.

[34]  Hwee Tong Tan,et al.  Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. , 2012, Journal of proteome research.

[35]  M. Kaminishi,et al.  Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. , 2011, Gastroenterology.

[36]  B. Honoré.  The rapidly expanding CREC protein family: members, localization, function, and role in disease , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  Yuquan Wei,et al.  Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid , 2008, Cancer Chemotherapy and Pharmacology.

[38]  Khean Lee Goh,et al.  Screening for gastric cancer in Asia: current evidence and practice. , 2008, The Lancet. Oncology.

[39]  H. Grønbæk,et al.  Serum Trefoil Factors in Patients with Inflammatory Bowel Disease , 2006, Digestion.

[40]  S. Poulsen,et al.  Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer , 2006, Clinical Cancer Research.

[41]  Troels Z. Kristiansen,et al.  Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach*S , 2006, Molecular & Cellular Proteomics.

[42]  D. Podolsky,et al.  Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Hishida,et al.  Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma. , 2014, International journal of oncology.